Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
11 hedge funds and large institutions have $50.5M invested in Zealand Pharma A/S American Depositary Shares in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
33% more capital invested
Capital invested by funds: $37.9M → $50.5M (+$12.6M)
8% less funds holding
Funds holding: 12 → 11 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.36M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$3.34M |
| 3 |
Millennium Management
New York
|
+$2.16M |
| 4 |
AIC
AWM Investment Company
New York
|
+$277K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$20K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
-$908K |
| 2 |
FAM
Fred Alger Management
New York
|
-$544K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$347K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$215K |
| 5 |
Jane Street
New York
|
-$121K |
ZEAL Hedge Fund Activity: Q1 2018 in Review
11 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q1 2018, worth a combined $50.5M — up 33% from $37.9M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZEAL and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.
The largest buyer was Wellington Management Group, adding an estimated $5.36M. The largest seller was Laurion Capital Management, cutting an estimated $908K.
- 11 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q1 2018, down from 12 in Q4 2017.
- Funds reported $50.5M of Zealand Pharma A/S American Depositary Shares stock for Q1 2018, up 33% quarter-over-quarter.
- 2 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q1 2018 and 3 closed out, a net change of -1 holder.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q1 2018 was Wellington Management Group, an estimated $5.36M added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q1 2018 was Laurion Capital Management, an estimated $908K sold.
Based on aggregated 13F filings for Q1 2018.